Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Some are diabetes treatments prescribed off-label, and, in some cases, manufacturers have rebranded and gained FDA approval specifically to treat obesity
The strongest data remain in weight loss and cardiometabolic outcomes, but arthritis-specific benefits are being actively studied, so excited to see where this goes
Tirzepatide produced approximately 22.5 percent at 72 weeks in SURMOUNT-1
However, researchers continue to study the issue, and the boxed warning remains important for people with specific risk factors
US$ 24.46
US$ 23.84
US$ 26.00
